Magnetic Resonance Venography Pre- and Post-Treatment in Patients With Idiopathic Intracranial Hypertension
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT02394067|
Recruitment Status : Unknown
Verified April 2016 by Jai Shankar, Nova Scotia Health Authority.
Recruitment status was: Not yet recruiting
First Posted : March 20, 2015
Last Update Posted : April 22, 2016
|Condition or disease||Intervention/treatment|
|Pseudotumor Cerebri||Other: Radiological Imaging|
|Study Type :||Observational|
|Estimated Enrollment :||20 participants|
|Official Title:||Magnetic Resonance Venography Pre- and Post-Treatment in Patients With Idiopathic Intracranial Hypertension|
|Study Start Date :||August 2016|
|Estimated Primary Completion Date :||August 2017|
|Estimated Study Completion Date :||September 2018|
Idiopathic Intracranial Hypertension
All participants of our study will be in this arm. These will be patients with a diagnosis of IIH. These patients will be followed throughout their standard of care treatment, with neuro-radiological imaging.
Other: Radiological Imaging
magnetic resonance imaging and magnetic resonance venography scans
- Transverse venous sinus stenosis (combined conduit score, and measure of transverse venous sinus stenosis, for each MRI/MRV) [ Time Frame: 4 MRI/MRV's performed within a year of diagnosis ]The main outcome measure will be a combined conduit score, and measure of transverse venous sinus stenosis, for each MRI/MRV.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02394067
|Contact: Jai Shankar, MD||(902) 473-5446||JaiJai.Shankar@cdha.nshealth.ca|
|Contact: Anastasia Neufeld, MD||(902) 473-2220||Anastasia.Neufeld@dal.ca|
|Principal Investigator:||Jai Shankar, MD||Capital Health, Canada|